GlassScriptPhysician profile
Eduardo E Pascual
NPI 1790700417
$10,304.67
in general payments reported to CMS, 2019-2025
39 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,519 · 2020: $1,501 · 2021: $2,759 · 2022: $1,845 · 2023: $1,444 · 2024: $972 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,681.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,635.60 | 2021-2024 | Micra, Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $1,455.57 | 2019-2025 | |
| Amgen INC. | $1,358.26 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $870.30 | 2019-2023 | Farxiga, Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $632.04 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $621.21 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $533.99 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $455.19 | 2019-2024 | Watchman Flx, Watchman Access System |
| Abbott Laboratories | $366.04 | 2019-2022 | |
| Esperion Therapeutics, INC. | $268.43 | 2020-2022 | |
| Pfizer INC. | $255.83 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $191.32 | 2019-2023 | |
| Atricure, INC. | $171.33 | 2022-2023 | |
| Novo Nordisk INC | $153.31 | 2022-2025 | Wegovy, Ozempic |
| Amarin Pharma, INC. | $141.06 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Pascual listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.